-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EsloMpewym2CjyO83SBC/qXT1vOGcba7Kiy+8VgMl3nRlqjKINh5N2d7sBR5KCzH 7JjwGyMyd/pARWAUuOrN8A== 0000919567-98-000025.txt : 19980209 0000919567-98-000025.hdr.sgml : 19980209 ACCESSION NUMBER: 0000919567-98-000025 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980206 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BENTLEY PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000821616 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 591513162 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-40113 FILM NUMBER: 98523711 BUSINESS ADDRESS: STREET 1: 4830 WEST KENNEDY BLVD STREET 2: SUITE 548 CITY: TAMPA STATE: FL ZIP: 33609 BUSINESS PHONE: 8132864401 MAIL ADDRESS: STREET 1: 4830 WEST KENNEDY BLVD STREET 2: SUITE 548 CITY: TAMPA STATE: FL ZIP: 33609 FORMER COMPANY: FORMER CONFORMED NAME: BELMAC CORP /FL/ DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: RENAISSANCE CAPITAL GROWTH & INCOME FUND III INC CENTRAL INDEX KEY: 0000919567 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 752533518 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 8080 N CENTRAL EXPRWY STREET 2: STE 210 LB59 CITY: DALLAS STATE: TX ZIP: 75206 BUSINESS PHONE: 2148918294 MAIL ADDRESS: STREET 1: 8080 N CENTRAL EXPWY., SUITE 210 LB 59 CITY: DALLAS STATE: TX ZIP: 75206 SC 13G 1 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. _____) BENTLEY PHARMACEUTICALS, INC. _________________________________________________________________________ (Name of Issuer) COMMON STOCK __________________________________________________________________________ (Title of Class of Securities) 082657107 __________________________ (CUSIP Number) 2 13G CUSIP No. __082657107__ _____________________________________________________________________________ 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. Renaissance Capital Growth & Income Fund III, Inc. 75-2533518 _____________________________________________________________________________ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) (b) _____________________________________________________________________________ 3. SEC USE ONLY _____________________________________________________________________________ 4. CITIZENSHIP OR PLACE OF ORGANIZATION Texas _____________________________________________________________________________ NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: _____________________________________________________________________________ 5. SOLE VOTING POWER 297,920 shares _____________________________________________________________________________ 6. SHARED VOTING POWER None _____________________________________________________________________________ 7. SOLE DISPOSITIVE POWER 297,920 shares _____________________________________________________________________________ 8. SHARED DISPOSITIVE POWER None _____________________________________________________________________________ 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 297,920 shares _____________________________________________________________________________ 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* Not applicable _____________________________________________________________________________ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 8.08% _____________________________________________________________________________ 12. TYPE OF REPORTING PERSON IV _____________________________________________________________________________ 3 ITEM 1. a, b. Bentley Pharmaceuticals, Inc. ( Company ) 4830 W. Kennedy Blvd., Suite 550 Tampa, FL 33609-2517 ITEM 2. (a) Name of Person Filing Renaissance Capital Growth & Income Fund III, Inc. ( Filer ) (b) Address of principal Business Office or, if none, Residence 8080 N. Central Expwy., Suite 210 LB-59 Dallas, TX 75206-1857 (c) Citizenship Texas (d) Title of Class of Securities Common Stock (e) CUSIP Number 75966V105 ITEM 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d- 2(b), check whether the person filing is a: (a) ______ Broker or Dealer registered under Section 15 of the Act (b) ______ Bank as defined in section 3(a)(6) of the Act (c) ______ Insurance Company as defined in section 3(a)(19) of the Act (d) __X___ Investment Company registered under section 8 of the Investment Company Act (e) ______ Investment Adviser registered under section 203 of the Investment Advisers Act of 1940 (f) ______ Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see section 240.13d- 1(b)(1)(ii)(F) (g) ______ Parent Holding Company, in accordance with section 240.13d-1(b)(ii)(G)(Note: See Item 7) (h) ______ Group, in accordance with section 240.13d-1(b)(1)(ii)(H) 4 Item 4. Ownership. (a) Amount Beneficially Owned: On February 12, 1996, the Company and the Filer entered into a 12% Convertible Debenture Loan Agreement for $800,000 due February 12, 2006, convertible at $2.50 per share. Each Debenture unit contains 1,000 Class A Warrants, each of which allows the Filer to buy one share of the Company at $3.00 per share and will expire in three years. Additionally, the Debenture includes 500 Class B Warrants, exercisable at $5.00 per share and have a five year life. From September 20, 1996 through January 27, 1997, the Filer sold the Class A and Class B Warrants and reduced its position in the Company to $744,800. (b) Percent of Class 8.08% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 297,920 (ii) shared power to vote or to direct the vote: None (iii) sole power to dispose or to direct the disposition of: 297,920 (iv) shared power to dispose or to direct the disposition of: None Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. 5 Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: January 20, 1998 ______________/S/__________________________ Signature Vance M. Arnold, Executive Vice President Renaissance Capital Group, Inc. Investment Advisor ___________________________________________ Name and Title -----END PRIVACY-ENHANCED MESSAGE-----